Elizabeth A. Czerepak
2017
In 2017, Elizabeth A. Czerepak earned a total compensation of $532.1K as Former Chief Financial Officer at PharmAthene, a 4% decrease compared to previous year.
Compensation breakdown
| Bonus | $20,250 |
|---|---|
| Option Awards | $172,000 |
| Salary | $327,366 |
| Other | $12,495 |
| Total | $532,111 |
Czerepak received $327.4K in salary, accounting for 62% of the total pay in 2017.
Czerepak also received $20.3K in bonus, $172K in option awards and $12.5K in other compensation.
Rankings
In 2017, Elizabeth A. Czerepak's compensation ranked 11,635th out of 14,666 executives tracked by ExecPay. In other words, Czerepak earned more than 20.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,635 out of 14,666 | 21st |
Division Manufacturing | 4,565 out of 5,768 | 21st |
Major group Chemicals And Allied Products | 1,668 out of 2,074 | 20th |
Industry group Drugs | 1,379 out of 1,730 | 20th |
Industry Pharmaceutical Preparations | 1,075 out of 1,329 | 19th |
Source: SEC filing on July 26, 2018.
Czerepak's colleagues
We found three more compensation records of executives who worked with Elizabeth A. Czerepak at PharmAthene in 2017.